
Kymera Therapeutics, Inc.
USD113.37
+2.31 (+2.08%)
CEO
Nello Mainolfi
IPO Date
2020-08-21
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$111.22
Prev. Close
$111.06
Day Low
$110.25
Day High
$113.83
52W Low
$36.65
52W High
$130.05
Market Cap
$9.33B
Volume
0.54M
| 29 Jun 2026 |
| B. Riley Securities |
| Buy |
| Buy |
| maintain |
| 29 Jun 2026 | Truist Securities | Buy | Buy | maintain |
| 26 Jun 2026 | Canaccord Genuity | Buy | Buy | maintain |
| 25 Jun 2026 | BTIG | Buy | Buy | maintain |
| 3 Mar 2026 | UBS | Buy | Buy | maintain |
| 2 Mar 2026 | Stephens & Co. | Overweight | Overweight | maintain |
| 2 Mar 2026 | Citigroup | Buy | Buy | maintain |